Cannara Biotech Inc. Financial Update Announcement
MONTREAL -- Cannara Biotech Inc. (TSXV: LOVE) is set to unveil its financial results for the fiscal fourth quarter and the year ending August 31, of the fiscal year 2025. The announcement is scheduled for Monday, November 24, at 7:00 a.m. ET.
Live Earnings Webcast
Following the financial results release, Cannara’s CEO Zohar Krivorot and CFO Nicholas Sosiak will host a live earnings webcast at 11:00 a.m. ET on the same day. The session will feature prepared remarks and an interactive question-and-answer segment, allowing participants to engage directly with the executives.
Participant Registration Details
Interested individuals can register for the earnings webcast through Cannara's event section on their website. For those who cannot attend the live session, there will be a recording available on the Cannara website after the event concludes.
Submitting Questions
Shareholders and interested parties are encouraged to submit questions beforehand via email. Although live questions will be permitted during the session, priority will be given to those submitted in advance, ensuring that the most pressing inquiries are addressed.
Board of Directors Update
Cannara Biotech also shares some somber news with the announcement of the passing of Jack M. Kay, a long-standing and highly regarded Board member. Mr. Kay’s contributions to Cannara since joining in 2019 included over five decades of leadership experience across the pharmaceutical and management sectors.
A Legacy of Excellence
During his esteemed career, Mr. Kay held several prominent roles, including CEO and COO at Apotex Inc., where he spent 35 years. His extensive experience included vital positions that shaped the trajectory of various pharmaceutical entities and community organizations, exemplifying his dedication beyond corporate responsibilities.
Community and Company Impact
The team at Cannara extends its heartfelt condolences to Mr. Kay’s family while honoring his remarkable contributions to the industry and his community. His vision and commitment have left an indelible mark on the corporation.
About Cannara Biotech Inc.
Cannara Biotech Inc. (TSXV: LOVE) is a dynamic player in the Canadian cannabis industry, combining quality and affordability in its offerings. With two expansive facilities located in Québec, boasting over 1,650,000 sq. ft. of operational space, Cannara produces up to 100,000 kg of cannabis annually.
The company stands out by harnessing Québec's efficient electricity rates, which enables them to deliver premium cannabis at competitive prices. Cannara's commitment to developing innovative cannabis products reflects its mission to enhance the consumer experience while maintaining sustainable practices.
Contact Information
For inquiries, please contact:
Nicholas Sosiak, CPA, CA
Chief Financial Officer
nick@cannara.ca
Zohar Krivorot
President & Chief Executive Officer
zohar@cannara.ca
Frequently Asked Questions
When will Cannara Biotech announce its financial results?
Cannara Biotech will announce its financial results on November 24, 2025, at 7:00 a.m. ET.
Who will lead the earnings webcast?
The webcast will be led by CEO Zohar Krivorot and CFO Nicholas Sosiak.
How can I register for the webcast?
You can register for the webcast on Cannara Biotech's official website under the events section.
What happened to Jack M. Kay?
Jack M. Kay, a valued member of the Board of Directors, has sadly passed away.
What makes Cannara Biotech stand out?
Cannara is known for its premium cannabis products and competitive pricing, developed in large facilities leveraging low operational costs.